Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Contemp Clin Trials. 2015 Feb 3;41:192–201. doi: 10.1016/j.cct.2015.01.018

Table 4. COPD-related Clinical Characteristics of Randomized Patients (N=305).

Variables Total UC PASM



N=305 % N=156 % N=149 %
BODE Index BODE Index 4.37 1.98 4.38 2.03 4.36 1.93
 BMI, mean(SD) 28.93 7.06 28.52 6.26 29.35 7.81
 FEV1 (%), mean(SD) 46.45 13.09 47.33 45.20 45.53 43.49
 MMRC Dyspnea, mean(SD) 1.83 0.95 1.85 0.94 1.81 0.96
 6MW Greater than 350m, n(%) 151 49.51 75 48.08 76 51.01

6 Minute Walk Total distance walked in 6 minutes(m), mean (SD) 340.05 93.68 337.50 96.37 342.80 91.03

GOLD Stage GOLD Stage, n(%)
 II 134 43.93 75 48.08 59 39.60
 III 130 42.62 59 37.82 71 47.65
 IV 41 13.44 22 14.10 19 12.75

Oxygen Use Currently using oxygen, n(%)
 Yes 122 40.00 67 42.95 55 36.91
 No 183 60.00 89 57.05 94 63.09

UC-Usual Care; PASM-Physical Activity Self-Management; SD-Standard deviation; BODE-Body Mass Index, Degree of Airflow Obstruction and Dyspnea, and Exercise Capacity; FEV1-Forced Expiratory Volume in 1 second; MMRC-modified medical research council; 6MW-6 Minute Walk; GOLD-Global Initiative for chronic Obstructive Lung Disease